REFERENCES
- Jaffe ES, Harris NL, Stein H, Pathology and Genetic of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
- Han X, Jorgensen JL, Brahmandam, A, Immunophenotypic study of basophils by multiparameter flow cytometry. Arch Pathol Lab Med. 2008;813–819.
- Schernthaner GH, Hausman AW, Baghestanian M, Detection of differentiation and activation linked cell surface antigens on cultured mast cell progenitors. Allergy. 2005;60:1248–1255.
- Ghannadan M, Hauswith AW, Schernthaner GH, Detection of novel CD antigens on the surface of human mast cells and basophils. Int Arch Allergy Immunol. 2002;127:299–307.
- Agis H, Fureder W, Bankl HC, Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology. 1996;87:535–543.
- Shapira MY, Hirshberg B, Amir G, 6;9 translocation in myelodysplastic syndrome. Cancer Genet Cytogenet. 1999;112:57–59.
- Garcon L, Libura M, Delabesse E, DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification. Leukemia. 2005;19:1338–1344.
- Oyarzo MP, Lin P, Glassman A, Acute myelogenous leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of FLT3 gene mutations. Am J Clin Pathol. 2004;122:348–358.
- Slovak ML, Gundacker H, Bloomfield CD, A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies. Leukemia. 2006;20:1295–1297.
- Thiede C, Steudel C, Mohr B, Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood. 2002;99(12):4326–4335.
- Yiqing C, Lindgren V, Quigley S, Gaitonde S. Acute myelogenous leukemia with t(6;9)(p23;q34) and marrow basophilia. An overview. Arch Pathol Lab Med. 2008;132:1835–1837.
- Schoch C, Haase D, Fonatsch C, The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group. Br J Haematol. 1997;99(3):605–611.
- Chevallier P, Lapobin M, Nagler A, Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT. Bone Marrow Transplant. 2009;44(9):589–594.
- Wolman SR, Gundacker H, Appelbaum FR, Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. Blood. 2002;100(1):29–35.
- Gupta R, Jain P, Anand M. Acute basophilic leukemia: a case report. Amer J Hematol. 2004;76: 134–138.
- Lorsbach RB, McNall R, Mathew S. Marked bone marrow basophilia in a child with acute myeloid leukemia with a cryptic t(8;21)(q22;q22) chromosomal translocation. Leukemia. 2001;15:1799–1801.
- Xue YQ, Guo Y, Lu DR, A case of basophilic leukemia bearing simultaneous translocations t(8;21) and t(9;22). Cancer Genet Cytogenet. 1991;51:215–221.